pill form glp-1 Eli Lilly Foundayo approved for obesity This gentle A new oral GLP-1 treatment

(2021) observed that heat-killed Lactococcus lactis MG5125 and various Lactobacillus strains suppressed nitric oxide production by up to 86.2% and reduced the expression of nitric oxide synthase and cyclooxygenase-2 induced by lipopolysaccharides

Oral GLP-1s (Lillys paltusotine-orforglipron, etc.) are expected in late 2025/2026, and might be covered differently (some plans treat orals less restrictively than injectables)

Pennington and Dr

And if everyones side-eyeing AI, help them see how it can actually work in their favor, and how your brand makes that possible

GLP-1 and GIP inhibitors are amazing medications at doing what they were developed for managing blood sugar in people with type 2 diabetes and weight loss in obesity, study co-author Kelly Allison, a professor of psychiatry and director of the Center for Weight and Eating Disorders at Penn, said in the news release

This helps maintain a steady level of the medication in your bloodstream